Skip to content

ERGOMED

Active
Private limited companyfounded 201511 yrs activeThier du Moulin 6, 4690 Bassenge, BelgiumKBO/BCE: BE 0597.596.313

ERGOMED has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-14k) and a net result of €20k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 27711 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).

Checked score

Score 2025
43 / 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+33
Solvency0=
Growth58=
Track record100
Bankruptcy probability, 12 months
1.4% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.65 against 0.55 in 2024; short-term debt: 153.5% of total assets), and equity is negative.
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 43
Relative position
BE, all sectors
reference
Sector 43
higher
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-53.5%
Return on assets
73.3%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 11 years 0 20 y
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 27711 sector peers (2025).
NBB · sector comparison
Position among 27711 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
29 d late
2024
31 d late
2023
48 d early
2022
29 d late
2021
31 d late
2020
13 d late
2019
11 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€20k▲ 301%
2024 · €5k
2018: €-1k 2019: €-30k 2020: €26k 2021: €8k 2022: €-13k 2023: €-72k 2024: €5k
2018 → 2025
Working capital
€-14k▲ 57.8%
2024 · €-34k
2018: €39k 2019: €11k 2020: €38k 2021: €45k 2022: €33k 2023: €-39k 2024: €-34k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€46k-€34k▼ 27.5%€-39k€-34k▲ 12.6%€-14k▲ 57.8%
Operating result€9k-€-11k€-69k▼ 500%€10k€23k▲ 134%
Net result€8k-€-13k€-72k▼ 468%€5k€20k▲ 301%
Result per fiscal year
Operating resultNet result
€-75k€-50k€-25k€0€25kOperating result 2021: €9k€9kNet result 2021: €8k€8kOperating result 2022: €-11k€-11kNet result 2022: €-13k€-13kOperating result 2023: €-69k€-69kNet result 2023: €-72k€-72kOperating result 2024: €10k€10kNet result 2024: €5k€5kOperating result 2025: €23k€23kNet result 2025: €20k€20k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 134% above 2024 and is the highest result in the available series.
Key figures and ratios
2025 value · change against 2024
Solvency
-53.5%
2024 · -82.2%
Current ratio
0.65
2024 · 0.55
Quick ratio
0.65
2024 · 0.46
Debt / equity
-2.87
2024 · -2.22
ROA
73.3%
2024 · 11.9%
Debt
€41k
2024 · €75k
Debt ≤ 1 year
€41k
2024 · €75k
Income taxes
€79
2024 · €304
Staff costs
€69
2024 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€41k€27k
Current assets29/58€41k€27k
Stocks and contracts in progress3€7k€167
Stocks30/36€7k€167
Amounts receivable within one year40/41€34k€27k
Trade receivables40€34k€27k
Other amounts receivable41€142-
Deferred charges and accrued income490/1€293-
Equity and liabilities
Total equity and liabilities10/49€41k€27k
Equity10/15€-34k€-14k
Contributions10/11€15k€15k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€-51k€-31k
Amounts payable17/49€75k€41k
Amounts payable within one year42/48€75k€41k
Financial debts43€20k€12k
Credit institutions430/8€20k€12k
Trade debts44€21k€4k
Suppliers440/4€21k€4k
Taxes, remuneration and social security45€10k€2k
Taxes450/3€7k€2k
Remuneration and social security454/9€4k€154
Other amounts payable47/48€23k€23k=
Income statement Code20242025
Remuneration, social security and pensions62€30k€69
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-4k€-66
Other operating charges640/8€2k€446
Non-recurring operating charges66A€14k€3k
Gross operating margin9900€51k€26k
Operating profit (loss)9901€10k€23k
Financial income75/76B€258-
Recurring financial income75€258-
Financial charges65/66B€5k€3k
Recurring financial charges65€5k€3k
Profit (loss) for the period before taxes9903€5k€20k
Income taxes67/77€304€79
Profit (loss) for the period9904€5k€20k
Profit (loss) for the period to be appropriated9905€5k€20k
Appropriation of the result
Profit (loss) to be appropriated9906€-51k€-31k
Profit (loss) brought forward from the previous period14P€-56k€-51k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
29-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 29 days late
2025
31-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 31 days late
2024
31-12
Financial Back to profitnet €5k
Net result €5k after 2 loss-making years.
13-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet €-72k
Net result drops to €-72k, the lowest in the series; recovery starts the following year.
29-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
31-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 31 days late
2021
13-08
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 13 days late
2020
31-12
Financial Back to profitnet €26k
Net result €26k after 2 loss-making years.
11-08
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 11 days late
2019
13-08
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 13 days late
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 31 days late
2017
31-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bassenge · 1 establishment unit since 2015
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Thier du Moulin 64690 Bassenge
Ground area
1.1 ha
Building footprint
816 m²
Volume, LiDAR
7,501 m³
2 parcels, Wallonia · tallest building 15.1 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
ERGOMED
Chaussée de Ramioul(IVR) 184, 4400 FlémalleManufacture of medical and dental instruments and supplies
since 20152.240.058.018
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62083A0157/00Y000 Wallonia 9,551 m² 1 · 697 m² 15.1 m · 4 fl.
62017C0295/00G000 Wallonia 1,586 m² 1 · 119 m² 8.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 15,529 companies in sector 43990 we hold annual accounts for 7,423. 5,786 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded03-02-2015
Fiscal year end31-12
Activities, NACEBEL
43990Other specialised construction activities
43999Specialised construction activities
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.